Vetter And Sentry Biopharma Services Establish Preferred Partnership Agreement
|| Print ||
|Tuesday, 04 May 2010 09:00 (UTC + 2)|
Supports a streamlined path from filling lab to clinic for early-stage study drugs
Skokie, Ill., and Indianapolis, Ind., May 4, 2010 / b3c newswire / – Vetter, a leading provider of aseptic pre-filled drug-delivery systems, and Sentry BioPharma Services, a provider of supply chain management and clinical packaging services, today announced that they have signed a preferred partnership agreement. Vetter will fill early-stage, high-value biopharmaceuticals at its Chicago facility; Sentry will label, package and ship the clinical supplies from its site in Indianapolis, Indiana. The collaboration will help streamline the path of study drugs from filling lab to clinic while safeguarding product integrity.
Said Peter Soelkner, Vetter managing director, “Our partnership with Sentry affirms our mutual commitment to helping clients get high-quality products to market quickly and efficiently. It also affirms Vetter’s commitment to the North American market.” The Chicago facility, which focuses on preclinical to phase II projects, is Vetter’s first outside of Germany and is an expansion of Vetter Development Service. It will be operational at the beginning of Q4 2010.
“We’re proud to partner with Vetter,” said Jennifer Marcum Sentry’s chief executive officer. “Both of our companies share the same dedication to the quality and safety of our clients’ products.” Sentry was recently awarded a contract by The Centers for Disease Control & Prevention (CDC) to store and distribute influenza vaccine for the U.S. National Strategic Reserve. “In addition, we’re both privately held companies with central U.S. locations allowing rapid response to industry needs and accessibility to clients across North America.”
About Vetter - www.vetter-pharma.com
Vetter Development Service provides development support for its pharmaceutical and biotech clients, from preclinical development to regulatory approval and worldwide product launch. Vetter Commercial Manufacturing performs the entire production process, from compounding and aseptic filling to final product packaging. Vetter Solutions’ patented drug-delivery systems enable clients to compete more effectively throughout the world.
About Sentry BioPharma Services - www.sentrybps.com
Sentry’s management team offers expertise in cold chain storage and logistics, quality assurance, pharmaceutical packaging and kitting development. Sentry also offers strategic solutions for domestic and international transportation and logistics as well as end-to-end import and export management. The company’s validated processes and inventory tracking systems are FDA compliant, adhere to current Good Manufacturing Practices (cGMPs) and comply with stringent standard operating procedures (SOP) outlined in Sentry’s Validation Master Plan. Sentry is VAWD® accredited, which ensures its storage, handling and distribution methods meet the recognized guidelines of the National Association of Board of Pharmacy®. The company is privately-held and strategically headquartered in Indianapolis, Ind.
For more information contact:
Sentry BioPharma Services